Patents by Inventor Ronald A. Wohl

Ronald A. Wohl has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD FOR REMOVING ACIDS FROM ORGANIC SOLVENTS
    Publication number: 20230356210
    Abstract: The present invention relates to methods of regenerating ion exchange resins in systems using anhydrous organic solvents, such as systems for alkaliating or lithiating materials, such as anodes, in gamma-butyrolactone.
    Type: Application
    Filed: January 27, 2023
    Publication date: November 9, 2023
    Inventors: Joanna L. Sparkes Turteltaub, Christopher J. Allen, Suraj S. Deshpande, Ronald A. Wohl, Asela Maha Acharige
  • PHASED INTRODUCTION OF LITHIUM INTO THE PRE-LITHIATED ANODE OF A LITHIUM ION ELECTROCHEMICAL CELL
    Publication number: 20230117752
    Abstract: The present invention relates to a method for combining anode pre-lithiation, limited-voltage formation cycles, and accelerating aging via heated storage to maximize specific capacity, volumetric capacity density and capacity retention of a lithium-ion electrochemical cell.
    Type: Application
    Filed: September 23, 2022
    Publication date: April 20, 2023
    Inventors: Robert W. Grant, Matthew Sweetland, Asela Maha Acharige, Ronald Wohl
  • METHOD FOR FORMING AN SEI LAYER ON AN ANODE
    Publication number: 20220376219
    Abstract: The present invention relates to a method for forming an SEI layer on an anode by using a non-electrochemical process for alkaliating anodes, resulting in reductions of the manufacturing capital requirements, time investments and energy consumed during industrial battery production.
    Type: Application
    Filed: June 6, 2022
    Publication date: November 24, 2022
    Inventors: Jose A. Vega, Asela Maha Acharige, Ronald A. Wohl
  • Method for forming an SEI layer on an anode
    Patent number: 11380879
    Abstract: The present invention relates to a method for forming an SEI layer on an anode by using a non-electrochemical process for alkaliating anodes, resulting in reductions of the manufacturing capital requirements, time investments and energy consumed during industrial battery production.
    Type: Grant
    Filed: July 9, 2018
    Date of Patent: July 5, 2022
    Assignee: Nanoscale Components, Inc.
    Inventors: Jose A. Vega, Asela Maha Acharige, Ronald A. Wohl
  • METHOD FOR FORMING AN SEI LAYER ON AN ANODE
    Publication number: 20200161625
    Abstract: The present invention relates to a method for forming an SEI layer on an anode by using a non-electrochemical process for alkaliating anodes, resulting in reductions of the manufacturing capital requirements, time investments and energy consumed during industrial battery production.
    Type: Application
    Filed: July 9, 2018
    Publication date: May 21, 2020
    Inventors: Jose A. Vega, Asela Maha Acharige, Ronald A. Wohl
  • PHASED INTRODUCTION OF LITHIUM INTO THE PRE-LITHIATED ANODE OF A LITHIUM ION ELECTROCHEMICAL CELL
    Publication number: 20180040914
    Abstract: The present invention relates to a method for combining anode pre-lithiation, limited-voltage formation cycles, and accelerating aging via heated storage to maximize specific capacity, volumetric capacity density and capacity retention of a lithium-ion electrochemical cell.
    Type: Application
    Filed: August 24, 2017
    Publication date: February 8, 2018
    Inventors: Robert W. Grant, Matthew Sweetland, Asela Maha Acharige, Ronald Wohl
  • Phased introduction of lithium into the pre-lithiated anode of a lithium ion electrochemical cell
    Patent number: 9748599
    Abstract: The present invention relates to a method for combining anode pre-lithiation, limited-voltage formation cycles, and accelerating aging via heated storage to maximize specific capacity, volumetric capacity density and capacity retention of a lithium-ion electrochemical cell.
    Type: Grant
    Filed: January 29, 2014
    Date of Patent: August 29, 2017
    Assignee: NANOSCALE COMPONENTS, INC.
    Inventors: Robert W. Grant, Matthew Sweetland, Asela Maha Acharige, Ronald Wohl
  • PHASED INTRODUCTION OF LITHIUM INTO THE PRE-LITHIATED ANODE OF A LITHIUM ION ELECTROCHEMICAL CELL
    Publication number: 20140310951
    Abstract: The present invention relates to a method for combining anode pre-lithiation, limited-voltage formation cycles, and accelerating aging via heated storage to maximize specific capacity, volumetric capacity density and capacity retention of a lithium-ion electrochemical cell.
    Type: Application
    Filed: January 29, 2014
    Publication date: October 23, 2014
    Applicant: NANOSCALE COMPONENTS, INC.
    Inventors: Robert W. Grant, Matthew Sweetland, Asela Maha Acharige, Ronald Wohl
  • Derivatized alkanolamines as cardiovascular agents
    Patent number: 5051423
    Abstract: Novel derivatized alkanolamines of the following structural formula ##STR1## are described as useful cardiovascular agents. Most especially described is their usefulness as cardiovascular agents exhibiting an antiarrhythmic effect. Said antiarrhythmic effect is of a combination Class II/Class III variety. Pharmaceutical formulations containing such compounds are also described.
    Type: Grant
    Filed: July 13, 1988
    Date of Patent: September 24, 1991
    Assignee: Schering AG
    Inventors: Randall E. Lis, William C. Lumma, Jr., Thomas K. Morgan, Jr., Klaus Nickisch, Ronald A. Wohl
  • Novel N-[4-(aminosubstituted)phenyl]methanesulfonamides and their use as cardiovascular agents
    Patent number: 4906634
    Abstract: Novel N-[4-(aminosubstituted)phenyl]methanesulfonamides and their use as cardiovascular agents, especially as antiarrhythmic agents are described. Pharmaceutical formulations containing such compounds are also discussed.
    Type: Grant
    Filed: March 8, 1988
    Date of Patent: March 6, 1990
    Assignee: Schering A.G.
    Inventors: Stanley S. Greenberg, William C. Lumma, Jr., Klaus Nickisch, Ronald A. Wohl
  • 1-(4-Substituted phenyl)-1H-imidazoles compounds
    Patent number: 4851526
    Abstract: Novel 1-(4-substituted phenyl)-1H-imidazoles and their use as antiarrhythmic, anti-hypertensive and anti-ischemic agents is described. Pharmaceutical formulations containing such compounds are also discussed.
    Type: Grant
    Filed: September 4, 1987
    Date of Patent: July 25, 1989
    Assignee: Schering A.G.
    Inventors: Stanley S. Greenberg, Randall E. Lis, William C. Lumma, Jr., Klaus Nickisch, Ronald A. Wohl
  • Substituted 4-(1H-imidazol-1-yl)benzamides as antiarrhythmic agents
    Patent number: 4804662
    Abstract: Novel substituted 4-[1H-imidazol-1-yl]benzamides and their use in the treatment of cardiac arrthythmias especially as Class III or combination Class I/III antiarrhythmic agents is described. Pharmaceutical formulations containing such compounds are also disclosed.
    Type: Grant
    Filed: May 5, 1987
    Date of Patent: February 14, 1989
    Assignee: Schering A.G.
    Inventors: Klaus Nickisch, Randall E. Lis, William C. Lumma, Jr., Thomas K. Morgan, Jr., Ronald A. Wohl
  • Process for the preparation of imidazolonecarbonylarylimidazoles
    Patent number: 4709043
    Abstract: Novel imidazolonecarbonylarylimidazoles are described having cardiovascular properties, especially as cardiotonic agents in the treatment of congestive heart failure. Pharmaceutical formulations containing such compounds are also provided. Further, a novel process for the preparation of the compounds and intermediates useful thereto of this invention is disclosed.
    Type: Grant
    Filed: November 26, 1985
    Date of Patent: November 24, 1987
    Assignee: Schering A.G.
    Inventors: Paul W. Erhardt, Alfred A. Hagedorn, III, William C. Lumma, Jr., Ronald A. Wohl
  • Antiarrhythmic imidazoles
    Patent number: 4689341
    Abstract: The imidazolium salts described are useful as antiarrhythmic agents. A method of treating arrhythmia by increasing the refractoriness of cardiac tissue is provided as well as pharmaceutical formulations containing such imidazolium salts.
    Type: Grant
    Filed: July 3, 1986
    Date of Patent: August 25, 1987
    Assignee: Schering A.G.
    Inventors: Julius Diamond, William C. Lumma, Jr., Thomas K. Morgan, Jr., Ronald A. Wohl
  • Substituted sulfonamidobenzamides and method of treating arrhythmias
    Patent number: 4629739
    Abstract: Novel substituted sulfonamidobenzamides are described as useful antiarrhythmic agents. Their use in the treatment of cardiac arrhythmias, especially re-entrant arrhythmias, via the prolongation of the action potential of cardiac tissue is provided. Pharmaceutical formulations containing such compounds are also disclosed.
    Type: Grant
    Filed: September 23, 1985
    Date of Patent: December 16, 1986
    Assignee: Schering A.G.
    Inventors: David D. Davey, William C. Lumma, Jr., Ronald A. Wohl
  • Antiarrhythmic imidazoliums
    Patent number: 4613609
    Abstract: The imidazolium salts described are useful as antiarrhythmic agents. A method of treating arrhythmia by increasing the refractoriness of cardiac tissue is provided as well as pharmaceutical formulations containing such imidazolium salts.
    Type: Grant
    Filed: November 27, 1984
    Date of Patent: September 23, 1986
    Assignee: Schering A. G.
    Inventors: Julius Diamond, William C. Lumma, Jr., Thomas K. Morgan, Jr., Ronald A. Wohl
  • Antiarrhythmic imidazoliums
    Patent number: 4581370
    Abstract: The imidazolium salts described are useful as antiarrhythmic agents. A method of treating arrhythmia by increasing the refractoriness of cardiac tissue is provided as well as pharmaceutical formulations containing such imidazolium salts.
    Type: Grant
    Filed: July 12, 1983
    Date of Patent: April 8, 1986
    Assignee: Schering A.G.
    Inventors: Julius Diamond, William C. Lumma, Jr., Thomas K. Morgan, Jr., Ronald A. Wohl
  • Cardiotonic 1,3-dihydro-4-[[(imidazol-1-yl)aryl]carbonyl]imidazol-2-ones
    Patent number: 4556665
    Abstract: Novel imidazolonecarbonylarylimidazoles of the formula: ##STR1## are described having cardiovascular properties, especially as cardiotonic agents in the treatment of congestive heart failure. Pharmaceutical formulations containing such compounds are also provided. Further, a novel process for the preparation of the compounds and intermediates useful thereto of this invention is disclosed.
    Type: Grant
    Filed: July 9, 1984
    Date of Patent: December 3, 1985
    Assignee: Schering A.G.
    Inventors: Paul W. Erhardt, Alfred A. Hagedorn, III, William C. Lumma, Jr., Ronald A. Wohl
  • Substituted phenylalkenyl ammonium salts as antiarrhythimc agents
    Patent number: 4545995
    Abstract: The novel unsaturated arylalkyl ammonium salts described herein are useful as antiarrhythmic agents. A method of treating arrhythmia by increasing the refractoriness of cardiac tissue is provided, as well as pharmaceutical formulations containing such ammonium salts.
    Type: Grant
    Filed: July 12, 1983
    Date of Patent: October 8, 1985
    Assignee: Schering A.G.
    Inventors: William C. Lumma, Jr., Ronald A. Wohl
  • Substituted sulfonamidobenzamides, antiarrhythmic agents and compositions thereof
    Patent number: 4544654
    Abstract: Novel substituted sulfonamidobenzamides are described as useful antiarrhythmic agents. Their use in the treatment of cardiac arrhythmias, especially re-entrant arrhythmias, via the prolongation of the action potential of cardiac tissue is provided. Pharmaceutical formulations containing such compounds are also disclosed.
    Type: Grant
    Filed: March 20, 1984
    Date of Patent: October 1, 1985
    Assignee: Schering A.G.
    Inventors: David D. Davey, William C. Lumma, Jr., Ronald A. Wohl